ABHD11介导线粒体DNA转录抑制心梗后心肌细胞铁死亡
本研究通过小鼠心肌梗死模型结合RNA测序和单核RNA测序,探讨ABHD11在心肌细胞铁死亡中的作用。结果显示心梗后第7天铁死亡达峰且富集于梗死周边心肌细胞,ABHD11表达在小鼠和人类心梗心脏中持续下降。心脏特异性过表达ABHD11可减轻心肌细胞铁死亡并改善心功能,机制上ABHD11作为线粒体DNA转录共激活因子,通过增强TEFM-POLRMT相互作用恢复线粒体功能,减少脂质过氧化,经线粒体-核信号串扰抑制铁死亡。
要点
- 心梗后心肌细胞铁死亡于第7天达峰,主要富集在梗死周边区域。
- ABHD11过表达可减轻铁死亡并改善心功能,缺失则加重重构和心衰。
- ABHD11通过促进线粒体DNA转录,减少ROS和脂质过氧化,抑制铁死亡。
核心结论
- ABHD11介导的线粒体DNA转录通过协调线粒体-核信号串扰,减轻心梗后心肌细胞铁死亡,为缺血性心肌损伤提供新治疗策略。
研究设计与样本
- 本研究采用小鼠心肌梗死模型,结合时间序列超声心动图评估不同细胞死亡抑制剂的作用。
- 整合RNA测序与单核RNA测序数据,并利用线粒体保护剂进行功能挽救实验。
- 运用转录组学、非靶向脂质组学、定点突变、分子对接、免疫共沉淀等多种方法阐明机制。
主要发现
- 心梗后心脏铁死亡于第7天达到高峰,且富集于梗死周边心肌细胞。
- 线粒体功能障碍是心梗后心肌细胞铁死亡的关键驱动因素。
- ABHD11在小鼠和人类心梗心脏中表达一致下降,其转录受DNMT1介导的启动子高甲基化抑制。
- 心脏特异性过表达ABHD11显著减轻心肌细胞铁死亡并改善心功能,缺失则加重重构和心衰。
- ABHD11独立于其经典酶活性,作为线粒体DNA转录共激活因子增强TEFM-POLRMT相互作用。
临床怎么用
- 靶向ABHD11-线粒体DNA转录轴可能成为缺血性心肌损伤的潜在干预方向。
- 心梗后第7天铁死亡达峰提示该时间窗可能适合铁死亡相关干预策略的评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiomyocytes exhibit marked susceptibility to ferroptosis after myocardial infarction (MI), rendering ferroptosis inhibition a promising therapeutic strategy to mitigate ischemic myocardial injury. Although mitochondrial dysfunction is recognized as a core driver of ferroptosis, the potential role of mitochondrial DNA transcription in regulating cardiomyocyte ferroptosis remains unexplored. METHODS: To clarify the temporal role of the various modes of cell death in MI progression, we performed time-course echocardiography in MI models treated with various cell death inhibitors. To characterize the crucial process and molecular regulator in cardiomyocyte ferroptosis, we integrated RNA sequencing and single-nucleus RNA sequencing data from murine post-MI hearts and performed functional rescue experiments using mitochondrial protective agents. To determine the role of ABHD11 (αβ-hydrolase domain-containing protein 11) in cardiomyocyte ferroptosis and cardiac repair after MI, we used loss- and gain-of-function approaches. To elucidate the underlying mechanisms, we conducted transcriptomics, nontargeted lipidomics, site-specific mutagenesis, molecular docking, coimmunoprecipitation, native gel electrophoresis, proximity ligation assay, methylation-specific polymerase chain reaction, and chromatin immunoprecipitation assay. RESULTS: We found that cardiac ferroptosis peaked at day 7 after MI and was enriched in peri-infarct cardiomyocytes. Mitochondrial dysfunction was a key driver of cardiomyocyte ferroptosis after MI, and the lipid enzyme ABHD11 was identified as a potential regulator of both processes. ABHD11 expression was consistently reduced in mouse and human MI hearts, and its transcription was repressed by DNMT1 (DNA methyltransferase 1)-mediated promoter hypermethylation. Functionally, cardiac-specific overexpression of ABHD11 markedly alleviated cardiomyocyte ferroptosis and improved cardiac function after MI. Conversely, loss of ABHD11 in adult mice exacerbated pathological cardiac remodeling and heart failure. Mechanistically, independent of its canonical enzymatic activities, ABHD11 acted as a mitochondrial DNA transcription coactivator by enhancing the TEFM (mitochondrial transcription elongation factor)-POLRMT (mitochondrial RNA polymerase) interaction. This promoted mitochondrial DNA transcription, restored mitochondrial function, and reduced reactive oxygen species/PUFA-PLs (polyunsaturated fatty acid-containing glycerophospholipids)-driven lipid peroxidation and 4-hydroxynonenal generation. The reduction in 4-hydroxynonenal stabilized YY1 (Yin Yang 1), which subsequently regulated key ferroptosis-driving genes governing iron deposition, reactive oxygen species production, and polyunsaturated fatty acid lipids accumulation, further inhibiting lipid peroxidation and ferroptosis, and ultimately promoting cardiac recovery after MI. CONCLUSIONS: This study revealed that ABHD11-mediated mitochondrial DNA transcription attenuated cardiomyocyte ferroptosis after MI by orchestrating a mitochondrial-nuclear crosstalk, offering a novel therapeutic strategy for ischemic myocardial injury.
引用
- Liu, Chen, Zheng, et al. ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction. Circulation. 2026. PMID: 42576811. doi:10.1161/CIRCULATIONAHA.125.078593
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。